首页> 外文期刊>International Journal of Pharmaceutics >The effect of oil components on the physicochemical properties and drug delivery of emulsions: Tocol emulsion versus lipid emulsion.
【24h】

The effect of oil components on the physicochemical properties and drug delivery of emulsions: Tocol emulsion versus lipid emulsion.

机译:油成分对乳剂的理化性质和药物传递的影响:Tocol乳剂与脂质乳剂。

获取原文
获取原文并翻译 | 示例
           

摘要

An emulsion system composed of vitamin E, coconut oil, soybean phosphatidylcholine, non-ionic surfactants, and polyethylene glycol (PEG) derivatives (referred to as the tocol emulsion) was characterized in terms of its physicochemical properties, drug release, in vivo efficacy, toxicity, and stability. Systems without vitamin E (referred to as the lipid emulsion) and without any oils (referred to as the aqueous micelle system) were prepared for comparison. A lipophilic antioxidant, resveratrol, was used as the model drug for emulsion loading. The incorporation of Brij 35 and PEG derivatives reduced the vesicle diameter to <100nm. The inclusion of resveratrol into the emulsions and aqueous micelles retarded the drug release. The in vitro release rate showed a decrease in the order of aqueous micelle system>tocol emulsion>lipid emulsion. Treatment of resveratrol dramatically reduced the intimal hyperplasia of the injured vascular wall in rats. There was no significant difference in this reduction when resveratrol was delivered by either emulsion or the aqueous micelle system. The percentages of erythrocyte hemolysis by the emulsions and aqueous micelle system were approximately 0 and approximately 10%, respectively. Vitamin E prevented the aggregation of emulsion vesicles. The mean vesicle size of the tocol emulsion remained unchanged during 30 days at 37 degrees C. The lipid emulsion and aqueous micelle system, respectively, showed 11- and 16-fold increases in vesicle size after 30 days of storage.
机译:根据其理化性质,药物释放,体内功效,由维生素E,椰子油,大豆磷脂酰胆碱,非离子表面活性剂和聚乙二醇(PEG)衍生物组成的乳液体系(称为母育酚乳液)进行了表征。毒性和稳定性。制备没有维生素E(称为脂质乳剂)和没有任何油(称为水性胶束系统)的体系进行比较。亲脂性抗氧化剂白藜芦醇被用作加载乳剂的模型药物。 Brij 35和PEG衍生物的结合将囊泡直径减小至<100nm。在乳液和水性胶束中包含白藜芦醇可延缓药物释放。体外释放速率按水胶束体系>母育酚乳剂>脂质乳剂的顺序降低。白藜芦醇的治疗显着减少了大鼠受损血管壁的内膜增生。当通过乳液或水性胶束系统递送白藜芦醇时,这种减少没有显着差异。乳剂和水性胶束系统的红细胞溶血百分比分别约为0和约10%。维生素E阻止了乳液囊泡的聚集。母育酚乳剂的平均囊泡大小在37摄氏度下的30天中保持不变。脂质乳剂和水性胶束系统在储存30天后分别显示出11倍和16倍的囊泡大小增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号